Dermavant to Present at JMP Securities Life Science Conference

Tuesday, June 19, 2018 Lifestyle News
Email Print This Page Comment bookmark
Font : A-A+

BASEL, Switzerland, June 19, 2018 /PRNewswire/ -- Dermavant today announced that President and Chief Operating Officer

Vince Ippolito will present a corporate overview at the JMP Securities Life Science Conference on June 20, 2018 at 2:00 p.m. ET.

About Dermavant

Dermavant is dedicated

to developing and, upon regulatory approval, commercializing innovative therapies in medical dermatology. Dermavant currently has five investigational drugs in development: RVT-501, RVT-502, RVT-503, RVT-504, and RVT-201.

RVT-501 is a small molecule phosphodiesterase-4 (PDE4) inhibitor being developed as a topical therapy for patients with mild-to-moderate atopic dermatitis. RVT-502 is a small molecule dual spleen tyrosine kinase (Syk) and janus kinase (JAK) inhibitor being developed as a topical therapy for a variety of serious dermatologic conditions including atopic dermatitis. RVT-503 is a preclinical asset with a novel mechanism of action being studied for the treatment of acne. RVT-504 is a combination of a muscarinic antagonist with a muscarinic agonist being developed as an oral therapy for the treatment of hyperhidrosis. RVT-201 is a caspase-1 inhibitor that acts to inhibit the production of inflammatory cytokines and is being developed as a topical therapy for inflammatory skin diseases.

For more information, visit the company website at www.dermavant.com.

Contact

Ric PetersonChief Financial OfficerDermavant Sciences, Inc. Ric.Peterson@Dermavant.com 

Cision View original content:http://www.prnewswire.com/news-releases/dermavant-to-present-at-jmp-securities-life-science-conference-300668168.html

SOURCE Dermavant



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store